Sundström C, Sällström J, Nilsson K
J Clin Lab Immunol. 1980 Mar;3(2):99-103.
Spontaneous rosetting with mouse red blood cells (MRBC) seems to be a marker for a subpopulation of B-lymphocytes. We investigated the capacity of different hematopoietic cell lines to form rosettes with MRBC. The cell lines represent different hematopoietic malignancies and the results with these lines were compared with those obtained with non-malignant EBV carrying lymphoblastoid cell lines (LCL). Among tumor cell lines only exceptional lines, 1 myeloma and 2 leukemia lines, showed rosetting capacity with MRBC. Most LCL, however, bound MRBC. These results indicate that only 1 category of established hematopoietic cell line, the LCL, has MRBC receptors and that thus a further subset of B-lymphocyte, the one represented by LCL, has the capacity for rosetting with MRBC. This MRBC rosetting of LCL is, however, not restricted to those lines with S-IgM. Tumor lines of hematopoietic origin seem, however, in general to lack MRBC receptors, even such lines that are derived from malignant lymphomas which express other B-lymphocyte characteristics.
与小鼠红细胞(MRBC)的自发玫瑰花结形成似乎是B淋巴细胞亚群的一个标志物。我们研究了不同造血细胞系与MRBC形成玫瑰花结的能力。这些细胞系代表不同的造血系统恶性肿瘤,并将这些细胞系的结果与携带EB病毒的非恶性淋巴母细胞系(LCL)的结果进行了比较。在肿瘤细胞系中,只有个别细胞系,1个骨髓瘤细胞系和2个白血病细胞系,显示出与MRBC形成玫瑰花结的能力。然而,大多数LCL能结合MRBC。这些结果表明,在已建立的造血细胞系中,只有一类,即LCL,具有MRBC受体,因此,由LCL代表的B淋巴细胞的另一个亚群具有与MRBC形成玫瑰花结的能力。然而,LCL的这种MRBC玫瑰花结形成并不局限于那些具有S-IgM的细胞系。然而,造血来源的肿瘤细胞系通常似乎缺乏MRBC受体,即使是那些源自表达其他B淋巴细胞特征的恶性淋巴瘤的细胞系也是如此。